NCCN Guidelines Version 3.2025
- Esophageal and Esophagogastric Junction Cancers
NCCN Guidelines with Evidence Blocks Version 2.2025
Basic Framework (English) Version 1.2024
Core Framework (English) Version 1.2024
Enhanced Framework (English) Version 1.2024
Esophageal Cancer-English Version 2024
Calendar of Events
Continuing Education
Archived NCCN Tumor Boards: Immune Checkpoint Inhibitors for First-Line Therapy in Esophagogastric/Esophagogastric Junction Cancer
Optimizing Patient Outcomes - Understanding the Mismatch Repair Deficient (dMMR)/Microsatellite-High (MSI-H) Treatment Options in Upper Gastrointestinal Cancers
Translations
Chinese Version 3.2022
Harmonized
English (Africa) Version 3.2023
Disclosure Policy
Panel Member Disclosures
Panel Member Disclosures by Meeting Date
End User License Agreement